Prescient Therapeutics (ASX:PTX) appointed Marissa Lim as Chief Medical Officer, effective Monday, according to a same-day filing with the Australian bourse.
Lim succeeds CMO Terrence Chew, who will continue with the company in an advisory capacity, per the filing.
The clinical-stage oncology company's shares were down 4% in recent trade.